Europe - EPA:ALGBE - FR0011052257 - Common Stock
The current stock price of ALGBE.PA is 0.0225 EUR. In the past month the price decreased by -36.62%. In the past year, price decreased by -98.02%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2OY.DE | DOW INC | 351.67 | 14.96B | ||
| FPE3.DE | FUCHS SE-PREF | 18.09 | 5.24B | ||
| BEWI.OL | BEWI AS | N/A | 4.14B | ||
| FPE.DE | FUCHS SE | 14.1 | 4.08B | ||
| SOLV.BR | SOLVAC SA-REG | 15.28 | 1.92B | ||
| EXPL.PA | EXPLOSIFS PROD. CHI | 16.93 | 442.96M | ||
| HYDRA.AS | HYDRATEC INDUSTRIES NV | 11.73 | 235.30M | ||
| SERI.MI | SERI INDUSTRIAL SPA | 5.77 | 149.52M | ||
| ALCRB.PA | CARBIOS | N/A | 126.54M | ||
| IBU.DE | IBU-TEC ADVANCED MATERIALS A | N/A | 95.00M | ||
| HOLCO.AS | HOLLAND COLOURS NV | 14.74 | 86.86M | ||
| ALAFY.PA | AFYREN SAS | N/A | 57.96M |
Global Bioenergies SA develops industrial processes to convert renewable sources into isobutene. The company is headquartered in Evry, Ile-De-France and currently employs 43 full-time employees. The company went IPO on 2011-06-09. Isobutene, a hydrocarbon, can be converted into fuels such as isooctane, as well as into various materials (synthetic rubber, organic glass, plastics). The process developed by Global Bioenergies SA is based on the design of an artificial metabolic pathway comprising several enzymes catalyzing reactions not observed in nature. Six patent applications have been filed by the Company. The first two applications covering the key steps of the bio-production of isobutene and other olefins have already been published. The company distributes butane and propane containing bio-isobutene, in a e partnership with Global Bioenergies. The company operates through Syngip.
GLOBAL BIOENERGIES SA
5, rue Henri Desbrueres
Evry ILE-DE-FRANCE FR
Employees: 43
Phone: 33164982050
Global Bioenergies SA develops industrial processes to convert renewable sources into isobutene. The company is headquartered in Evry, Ile-De-France and currently employs 43 full-time employees. The company went IPO on 2011-06-09. Isobutene, a hydrocarbon, can be converted into fuels such as isooctane, as well as into various materials (synthetic rubber, organic glass, plastics). The process developed by Global Bioenergies SA is based on the design of an artificial metabolic pathway comprising several enzymes catalyzing reactions not observed in nature. Six patent applications have been filed by the Company. The first two applications covering the key steps of the bio-production of isobutene and other olefins have already been published. The company distributes butane and propane containing bio-isobutene, in a e partnership with Global Bioenergies. The company operates through Syngip.
The current stock price of ALGBE.PA is 0.0225 EUR. The price decreased by -5.06% in the last trading session.
ALGBE.PA does not pay a dividend.
ALGBE.PA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
GLOBAL BIOENERGIES SA (ALGBE.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.32).
GLOBAL BIOENERGIES SA (ALGBE.PA) has a market capitalization of 408.82K EUR. This makes ALGBE.PA a Nano Cap stock.
ChartMill assigns a fundamental rating of 2 / 10 to ALGBE.PA. Both the profitability and financial health of ALGBE.PA have multiple concerns.
Over the last trailing twelve months ALGBE.PA reported a non-GAAP Earnings per Share(EPS) of -0.32. The EPS increased by 33.31% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -60.73% | ||
| ROE | -346.31% | ||
| Debt/Equity | 2.78 |
For the next year, analysts expect an EPS growth of 22.81% and a revenue growth 0.97% for ALGBE.PA